All questions
Guidelines: Xarelto (rivaroxaban) in nonvalvular atrial fibrillation
2 questions · 1 source
Questions that apply to every indication of Xarelto are on Xarelto (rivaroxaban), all indications.
Guidelines
Xarelto and the 2023 AF guideline: are DOACs recommended over warfarin?
Note: In the flashcard, both recommendations are Class I (Strong), Level of Evidence A (High-quality). These are class recommendations of the 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline for direct oral anticoagulants (DOACs), as reproduced in the guideline flashcard that the Xarelto HCP site links; they do not name XARELTO.
Xarelto in severe obesity: what does the 2023 AF guideline say about DOACs?
Note: In the flashcard, the first recommendation is Class 2a (Moderate), Level of Evidence B-NR, and the second Class 2b (Weak), Level of Evidence C-LD. These are class recommendations of the 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline for direct oral anticoagulants (DOACs), as reproduced in the guideline flashcard that the Xarelto HCP site links; they do not name XARELTO.